Company Overview
Snapshot
Founded in January 2023 by Lee Shleifer and Moshe Haimann, SafeShot operates with 1–10 employees. The company has secured funding across one round from Headstart. In May 2023, SafeShot received funding from Headstart.
Business overview
SafeShot develops a compact, multi-use device designed to detect GHB and ketamine in beverages. The technology relies on a chemical reaction that activates an electronic mechanism, sending an alert to a user's cell phone and contacting their emergency contacts. Operating within the Agriculture & Food Technologies sector, specifically Food Tech and Food Trade & Services, SafeShot targets consumers, particularly in recreational and lifestyle settings, as well as the food retail and restaurant industries.
Strategic signal
In May 2023, SafeShot's innovative device for detecting date-rape drugs in beverages was highlighted in a Geektime article. This signals a potential for the company to address a critical safety concern in social environments, positioning SafeShot as a relevant player in personal safety technology within the food and beverage industry.
Log in to access full profile ›Company Intelligence Q&A
- What is SafeShot's core technology?
- SafeShot's core technology is a small, multi-use device that detects GHB and ketamine in drinks. It utilizes a patented chemical and electronic system that triggers an alert to a user's cell phone and contacts upon drug detection.
- When was SafeShot founded and by whom?
- SafeShot was founded in January 2023 by Lee Shleifer, who serves as Co-founder & CEO, and Moshe Haimann, Co-founder & COO.
- What markets does SafeShot target?
- SafeShot targets consumers in recreational and lifestyle settings, as well as businesses within the food retail and restaurant sectors, focusing on personal safety in the food and beverage industry.
- What is the current product stage of SafeShot?
- SafeShot is currently in the R&D product stage, developing its drug detection device.